| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 594.080.143 $ | +147.738.403 $ | +614,4 % | 7 | 438.744.276 $ | +170.800.880 $ | +179,1 % | 5 | 469.385.378 $ | +148.080.451 $ | +40,0 % | 7 | 312.255.864 $ | +64.020.554 $ | +23,8 % | 6 | ||||
| Stoke Therapeutics, Inc. | STOK | → 0 | Stark | 155.105.193 $ | -16.439.160 $ | -9,6 % | 1 | 171.544.353 $ | +61.663.100 $ | +56,1 % | 1 | 109.881.253 $ | +48.538.203 $ | +79,1 % | 1 | 61.343.050 $ | +26.151.722 $ | +74,3 % | 1 |
| GH Research PLC | GHRS | → 0 | Schwach | 151.331.829 $ | +19.168.327 $ | +14,5 % | 1 | 132.163.502 $ | +27.851.823 $ | +26,7 % | 1 | 104.311.679 $ | +22.066.346 $ | +26,8 % | 1 | 82.245.333 $ | +11.168.675 $ | +15,7 % | 1 |
| Merus N.V. | → 0 | 144.439.375 $ | +61.918.338 $ | +75,0 % | 1 | 82.521.037 $ | +16.488.519 $ | +25,0 % | 1 | ||||||||||
| Cullinan Therapeutics, Inc. | CGEM | → 0 | Schwach | 127.371.335 $ | +34.599.110 $ | +37,3 % | 1 | 92.772.225 $ | +58.579.311 $ | +171,3 % | 1 | 34.192.914 $ | +1.054.574 $ | +3,2 % | 1 | 33.138.340 $ | +8.795.324 $ | +36,1 % | 1 |
| AGIOS PHARMACEUTICALS, INC. | AGIO | → 0 | Neutral | 88.349.345 $ | +86.181.980 $ | +3.976,3 % | 1 | ||||||||||||
| Protagonist Therapeutics, Inc | PTGX | → 0 | Neutral | 46.501.930 $ | +5.988.246 $ | +14,8 % | 1 | 40.513.684 $ | +5.065.127 $ | +14,3 % | 1 | ||||||||
| Denali Therapeutics Inc. | DNLI | → 0 | Schwach | 36.101.818 $ | +7.395.056 $ | +25,8 % | 1 | 28.706.762 $ | +24.907.067 $ | +655,5 % | 1 | ||||||||
| C4 Therapeutics, Inc. | CCCC | → 0 | Neutral | 18.407.112 $ | +4.849.678 $ | +35,8 % | 1 | 13.557.434 $ | -2.200.421 $ | -14,0 % | 1 | 15.757.855 $ | +5.607.525 $ | +55,2 % | 1 | ||||
| Korro Bio, Inc. | KRRO | → 0 | Neutral | 17.413.511 $ | +11.983.412 $ | +220,7 % | 1 | ||||||||||||
| TScan Therapeutics, Inc. | TCRX | → 0 | Neutral | 14.300.372 $ | +2.907.219 $ | +25,5 % | 1 | ||||||||||||
| Allogene Therapeutics, Inc. | ALLO | → 0 | Neutral | 12.494.420 $ | -3.648.813 $ | -22,6 % | 1 | ||||||||||||
| 594.080.143 $ | +147.738.403 $ | +614,4 % | 7 | 438.744.276 $ | +170.800.880 $ | +179,1 % | 5 | 469.385.378 $ | +148.080.451 $ | +40,0 % | 7 | 312.255.864 $ | +64.020.554 $ | +23,8 % | 6 | ||||